News
A new trial finds guselkumab is highly effective and well tolerated for moderate to severe scalp psoriasis in individuals ...
Patients with moderate to severe atopic dermatitis experienced a 71% decrease in Eczema Area and Severity Index scores from ...
This scale provided a measure of the broader impact of join pain and stiffness symptoms. Two single-item 7-point global rating of change scales for joint pain and stiffness were used to evaluate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results